Levofloxacin vs Nivolumab
Levofloxacin vs Nivolumab: Overview
This comparison examines the pharmacological differences between Levofloxacin and Nivolumab.
Mechanism of Action
Levofloxacin: Fluoroquinolone antibiotic inhibiting bacterial DNA gyrase and topoisomerase IV.
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Pharmacokinetics
Half-life: Levofloxacin β 6-8 hours; Nivolumab β 27 days.
Chemical Properties
Molecular Formula: Levofloxacin β C18H20FN3O4.
Molecular Weight: Levofloxacin β 361.3680 g/mol.
Type: Levofloxacin β Small molecule; Nivolumab β Antibody.